Results 171 to 180 of about 9,279 (208)
Some of the next articles are maybe not open access.

SYNCHRONIZATION OF ESTRUS IN CATTLE BY INTRAVAGINAL APPLICATION OF PROGESTERONE WITH ESTROGEN ADMINISTRATION

Canadian Journal of Animal Science, 1971
not available
W. J. Neville   +3 more
openaire   +2 more sources

Intravaginal Controlled Administration of Flurogestone Acetate II: Development of an In Vitro System for Studying the Intravaginal Release and Permeation of Flurogestone Acetate

Journal of Pharmaceutical Sciences, 1984
A relatively simple and easily constructed in vitro system was developed for studying the mechanism of release and intravaginal absorption of flurogestone acetate from vaginal sponges. The stability-indicating high-performance liquid chromatographic method developed earlier was used to provide a rapid, reproducible, and sensitive assay.
Yie W. Chienx, Mohan B. Kabadi
openaire   +3 more sources

Development of a Liposome Based Contraceptive System for Intravaginal Administration of Progesterone

Drug Development and Industrial Pharmacy, 1997
AbstractProgesterone bearing liposomes were prepared by the cast film method and characterized for various physical attributes. The liposomes could encapsulate nearly 98% of the drug. The progesterone bearing liposomes were incorporated into polyacrylamide gel and the drug content was determined.
Sanjay Jain, Ranjit Singh, Balram Sahu
openaire   +2 more sources

Radioimmunoassay of serum medroxyprogesterone acetate (Provera ®) in women following oral and intravaginal administration

Steroids, 1975
A radioimmunoassay (RIA) method for measuring medroxyprogesterone acetate (MPA, Provera) in serum has been developed utilizing benzene:iso-octane extraction, 3H-MPA to assess procedural losses, goat anti-MPA-3-(0-carboxymethyl) oxime-bovine serum albumin serum and dextran-coated charcoal separation.
Daniel R. Mishell   +5 more
openaire   +3 more sources

Mid-trimester abortion induced by intravaginal administration of prostaglandin F 2α-methylester suppositories

Contraception, 1978
Abstract Mid-trimester abortion was successfully induced in 28 of 31 patients by administration of vaginal prostaglandin F 2 α-methylester. A suppository containing 1.5 mg was given every three hours. Two of the patients who failed to abort needed a D & C after 24 and 30 hours.
A A Hospels, A. S. Van Den Bergh
openaire   +4 more sources

Oestrous synchronisation in ethiopian highland zebu cattle by means of intravaginal cloprostenole administration

Tropical Animal Health and Production, 1996
Two series were used in studying the use of a low dose of intravaginal cloprostenole in oestrous synchronisation of zebu cows. In series I, 39 cows were given 175 mcg of cloprostenole with a plastic catheter in the anterior vagina twice, with a 12-day interval.
Kalevi Heinonen   +2 more
openaire   +2 more sources

Systemic Absorption of Clindamycin after Intravaginal Administration of Clindamycin Phosphate Ovule or Cream

The Journal of Clinical Pharmacology, 1999
The absolute bioavailability of clindamycin phosphate vaginal ovule with comparison to a reference treatment of clindamycin phosphate sterile solution, as well as the relative bioavailability of the ovule compared to clindamycin phosphate vaginal cream, was evaluated in 12 healthy adult female volunteers.
Nancy K. Hopkins   +2 more
openaire   +3 more sources

Intravaginal administration of an inactivated vaccine prevents lesions induced by caprine herpesvirus-1 in goats

Vaccine, 2007
To evaluate the efficacy of mucosal vaccination with a beta-propiolactone inactivated caprine herpesvirus-1 (CpHV-1) vaccine, goats received vaginal administrations of two 7-day cycles at 2 weeks intervals. Seven days after the end of the second cycle, goats were challenged intravaginally with 4 ml of virulent BA.1 strain of CpHV-1.
CAMERO, Michele   +6 more
openaire   +4 more sources

Pharmacokinetics of progesterone in postmenopausal women:

European Journal of Drug Metabolism and Pharmacokinetics, 1998
Progesterone was administered to postmenopausal women in a form of vaginal suppositories containing 100 and 200 mg active substance in Butyrum cacao (BC) and Massa estarinum (ME), a base with emulsifying properties. In the case of single doses, blood samples were taken at 2, 4, 6, 24, 48 and 72 h.
A. Neagu   +5 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy